| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.32 | 4e-08 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.26 | 5e-06 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |